Home » Authors » Mark McCarty

Articles by Mark McCarty

House, Senate jockey on CHIP vote as expiration date nears

Sep. 26, 2007

By Mark McCarty

Administration policymakers see healthcare investment returns

Sep. 26, 2007

By Mark McCarty

Panel votes down proposal for non-RCTs for AF ablation use

Sep. 24, 2007

By Mark McCarty

Despite uncertainty, panel backs PMA for Repel CV anti-adhesive

Sep. 21, 2007

By Mark McCarty

Quality of heart failure care and P4P are targets at HFSA

Sep. 20, 2007

By Mark McCarty

VAD proponents see hope with concomitant use of clenbuterol

Sep. 19, 2007

By Mark McCarty

Researcher stumps for analyses to include registry data for ICDs

Sep. 18, 2007

By Mark McCarty

VeriChip controversy is said to hinge on iffy animal data

Sep. 13, 2007

By Mark McCarty

Brain mapping, imaging efforts furthered by NIH, DoD grants

Sep. 13, 2007

By Mark McCarty

House votes ‘for’ patent reform, but Senate seems in less hurry

Sep. 13, 2007

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...